80 participants
High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-06
- Start Date:
- 2026-08-01
- Completion:
- 2030-08-31
Conditions
- Prostate Cancer (Diagnosis)
- Prostate Cancer Stage IV
- CV Risk
Interventions
- OTHER
No Results Yet